H
301207
vs
AMGN
H
301207
AMGN
Over the past 12 months, Hualan Biological Bacterin Inc has outperformed AMGN, delivering a return of +23% compared to the AMGN's +18% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
301207
AMGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
H
Intrinsic Value
27.08
CNY
Undervaluation 27%
AMGN
Intrinsic Value
338.43
USD
Overvaluation 3%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc
SZSE:301207
|
19.75
CNY
|
|||||
|
Amgen Inc
NASDAQ:AMGN
|
349.82
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
301207, AMGN
301207, AMGN
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
H
|
Hualan Biological Bacterin Inc
Revenue
|
|||||||||||
|
|
Amgen Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
301207, AMGN
301207, AMGN
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
H
|
Hualan Biological Bacterin Inc
SZSE:301207
|
|||||||||
|
|
Amgen Inc
NASDAQ:AMGN
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Hualan Biological Bacterin Inc
77.3%
AMGN
82.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
Operating Margin
Hualan Biological Bacterin Inc
-2.9%
AMGN
44.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
Net Margin
Hualan Biological Bacterin Inc
7.1%
AMGN
21%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
FCF Margin
Hualan Biological Bacterin Inc
28.3%
AMGN
22%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
ROE
Hualan Biological Bacterin Inc
1.2%
AMGN
106.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
ROA
Hualan Biological Bacterin Inc
1%
AMGN
8.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
ROIC
Hualan Biological Bacterin Inc
-0.9%
AMGN
20.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
ROCE
Hualan Biological Bacterin Inc
-0.5%
AMGN
24.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
H
|
Hualan Biological Bacterin Inc | ||||
|
|
Amgen Inc | ||||
Solvency Comparison
H
Hualan Biological Bacterin Inc
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
301207, AMGN
301207, AMGN
Performance Gap
301207, AMGN
301207, AMGN
Performance By Year
301207, AMGN
301207, AMGN
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 301207 to other stocks
PNEXF
Pharnext SCA
More expensive
vs Hualan Biological Bacterin Inc
ABBV
Abbvie Inc
More expensive
vs Hualan Biological Bacterin Inc
GILD
Gilead Sciences Inc
More expensive
vs Hualan Biological Bacterin Inc
VRTX
Vertex Pharmaceuticals Inc
More expensive
vs Hualan Biological Bacterin Inc
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
S
|
Seagen Inc
F:SGT
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
